Good morning, and welcome to the CorMedix Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. Leading the call tod ...
NEUTROGUARD study: Phase III clinical study of DEFENCATH for prevention of CLABSI in adults on TPN via central venous catheter.
LucidLink Corp., provider of a cloud network-attached storage system based on object storage technology, today is introducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results